AthGene closed a Seed round (amount undisclosed) in May 2016. The company is based in Frederiksberg, Denmark. Data as of 7 Aug 2026.
Amount undisclosed or unconverted.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
No investors disclosed for this round.
